William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...

William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm ...

William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...

Biogen’s proposed acquisition comes after two difficult years of regulatory and clinical challenges, during which shares of ...

Exact Sciences' 2024 sales grew 10% to $2.76 billion, exceeding estimates. New cancer tests, including Cologuard Plus, are ...

The Fund seeks long-term capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of equity securities, including common ...